These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15923907)

  • 41. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
    CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract]   [Full Text] [Related]  

  • 42. Nicotinic acid in the treatment of hyperlipidaemia.
    Drexel H
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():5-6. PubMed ID: 18001312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hypolipidemic action of phospholipid compounds in experimental animals].
    Okunevich IV; Ryzhenkov VE; Ulesov AV; Makarevich IF; Mokrouz MV; Davigora IV
    Vopr Pitan; 1994; (3):19-21. PubMed ID: 7975417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evaluation and management of dyslipidemia in HIV-infected patients.
    Fichtenbaum CJ
    AIDS Clin Care; 2001 Dec; 13(12):113-7, 120. PubMed ID: 11769116
    [No Abstract]   [Full Text] [Related]  

  • 45. When to treat raised lipids.
    Jolleys J
    Practitioner; 1999 Jun; 243(1599):510-3, 515-6. PubMed ID: 10476570
    [No Abstract]   [Full Text] [Related]  

  • 46. [Increasing use of antilipemic agents].
    Reikvam A
    Tidsskr Nor Laegeforen; 1999 Jun; 119(16):2314-5. PubMed ID: 10414191
    [No Abstract]   [Full Text] [Related]  

  • 47. Advances in the management of hyperlipidemia-induced atherosclerosis.
    Tannock LR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy of low-dose atorvastatin and fenofibrate in mixed hyperlipidemia.
    Chatley P; Badyal DK; Calton R; Khosla PP
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):217-21. PubMed ID: 17520105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microsomal triglyceride transfer protein inhibition-friend or foe?
    Joy TR; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):506-8. PubMed ID: 18506153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New guidelines for the management of hyperlipidemia: change of diet is more effective than antilipemic agents].
    Hellström K
    Lakartidningen; 1988 Nov; 85(45):3807-8. PubMed ID: 3185040
    [No Abstract]   [Full Text] [Related]  

  • 55. [Eiconol effects on hemocoagulation in coronary heart disease patients].
    Dzhanashiia PK; Panchenko VM; Nazlukhanian SO; Chernova GI; Liutova LV; Semenov VA; Korneenkov VK; Perekrestova EI; Nurmukhamedov SA; Andreenko GI
    Klin Med (Mosk); 1997; 75(10):55-7. PubMed ID: 9490343
    [No Abstract]   [Full Text] [Related]  

  • 56. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hypolipidemic drugs and diabetes mellitus].
    Bláha V; Mistrík E
    Vnitr Lek; 2009 Apr; 55(4):357-62. PubMed ID: 19449750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Common obstacles in lipid management.
    Elpers M
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):287-95. PubMed ID: 18644511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fibrates in the treatment of hyperlipidemia].
    Kłosiewicz-Latoszek L; Szostak WB
    Wiad Lek; 1993 Nov; 46(21-22):872-6. PubMed ID: 7817584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.